Adagio Therapeutics Inc. (NASDAQ: ADGI) kicked off on June 21, 2022, at the price of $2.75, up 8.82% from the previous trading day. During the day, the shares moved up to $3.045 and dropped to $2.75 before settling in for the closing price of $2.72. Over the past 52 weeks, ADGI has traded in a range of $2.41-$78.82.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
While this was happening, its average annual earnings per share was recorded -784.00%. With a float of $77.20 million, this company’s outstanding shares have now reached $107.87 million.
In an organization with 101 employees, it is important to assess its efficiency.
Adagio Therapeutics Inc. (ADGI) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adagio Therapeutics Inc. is 24.30%, while institutional ownership is 68.20%.
Adagio Therapeutics Inc. (ADGI) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/30/2021, the organization reported -$0.77 earnings per share (EPS), higher than consensus estimate (set at -$1.03) by $0.26. This company achieved a return on equity of -68.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -784.00% per share during the next fiscal year.
Adagio Therapeutics Inc. (NASDAQ: ADGI) Trading Performance Indicators
Take a look at Adagio Therapeutics Inc.’s (ADGI) current performance indicators. Last quarter, stock had a quick ratio of 5.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.08, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -1.50 in one year’s time.
Technical Analysis of Adagio Therapeutics Inc. (ADGI)
Let’s dig in a bit further. During the last 5-days, its volume was 1.43 million. That was inferior than the volume of 3.07 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 32.77%. Additionally, its Average True Range was 0.25.
During the past 100 days, Adagio Therapeutics Inc.’s (ADGI) raw stochastic average was set at 5.67%, which indicates a significant decrease from 46.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.21% in the past 14 days, which was lower than the 111.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.01, while its 200-day Moving Average is $15.47. However, in the short run, Adagio Therapeutics Inc.’s stock first resistance to watch stands at $3.09. Second resistance stands at $3.21. The third major resistance level sits at $3.38. If the price goes on to break the first support level at $2.79, it is likely to go to the next support level at $2.62. The third support level lies at $2.50 if the price breaches the second support level.
Adagio Therapeutics Inc. (NASDAQ: ADGI) Key Stats
The company with the Market Capitalisation of 303.28 million has total of 109,715K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -226,790 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -100,670 K.